Interest Rates

Showing 2147 articles

Sanofi Halts mRNA Flu Vaccine Trial Amid Surging U.S. Influenza Season

French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.

Business

Aviat Networks: A Hidden Gem in Telecom Infrastructure?

Shares of Aviat Networks (NASDAQ: AVNW) have seen notable volatility, recently trading around $21.81. Analysis suggests the stock may be undervalued relative to industry peers, with strong future earnings growth projected. We examine whether this small-cap network specialist presents a timely opportunity for investors.